查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954694

药品检测设备市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2026-2034年）

Pharmaceutical Inspection Machines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

药品检测设备市场成长驱动因素

2025年全球药品检测设备市场规模为 10.221亿美元，预计将从2026年的11.032亿美元成长至2034年的22.635亿美元，预测期内年复合成长率（CAGR）为 9.40%。亚太地区将在2025年占据全球市场 37.20%的占有率，这反映了新兴经济体药品製造业的显着扩张。

药品检测设备是一种自动化和半自动化系统，用于药品生产，以确保产品品质、包装完整性和符合法规要求。这些系统能够侦测外观、尺寸和包装方面的缺陷，验证标籤和程式码，并识别肉眼不可见的缺陷。这些系统的应用能够提高生产效率，降低召回风险，确保病患安全，并支持序列化和防伪措施。

市场动态

市场驱动因素

日益严格的监管和品质合规要求是市场成长的主要驱动力。遵守FDA等监管机构和良好生产规范（GMP）的要求，需要对无菌生产、序列化和可追溯性进行严格的验证流程。先进的检测技术显着减少了因品质问题导致的药品召回。新兴地区药品生产外包的增加，进一步强化了各生产基地标准化检测系统的需求。

对病患安全和高品质药品的日益重视，迫使製造商将其传统的检测系统升级为自动化和人工智慧解决方案。

市场挑战

儘管成长潜力巨大，但巨额资本支出（CAPEX）仍然是一项重大挑战。采购除了需要获得监管部门的批准外，还需要经过漫长的实施确认（IQ）、运行确认（OQ）和效能确认（PQ）验证週期。这些延长的验证週期会导致采购决策延迟和设备升级週期延长，尤其对于中小型製造商而言更是如此。

市场机会

人工智慧驱动的检测系统和软体即服务（SaaS）平台的采用带来了巨大的成长机会。基于人工智慧的深度学习模型可以减少误报，提高侦测精度，并实现预测分析。订阅式监控和模型更新为供应商提供了持续的收入来源。

2021年 2月，Syntegon Technology 部署了首个经过全面验证的人工智慧驱动视觉检测系统，标誌着智慧製造领域的突破性进展。此外，工业4.0的整合，包括配备感测器的机械设备和互联生产线，加速药品企业的数位转型。

市场趋势

感测器融合和组合检测系统的整合是一个显着的趋势。製造商采用整合视觉系统、X射线检测、金属检测、楔入式检测和洩漏检测的平台，以减少生产线的占地面积并提高缺陷检测的准确性。

此外，个人化医疗和生物药品生产的兴起加速专门用于无菌注射剂和生物製品的检测工具的开发。

细分市场分析

依组件划分

到2026年，硬体细分市场将占82.19%的市场占有率，并创造7.841亿美元的收入。对自动化视觉检测（AVI）、X射线系统、洩漏检测系统和组合检测设备的强劲需求推动硬体市场的成长。

软体领域预计将以9.6%的年复合成长率（CAGR）实现最高成长，这主要得益于人工智慧分析、序列化系统以及追踪溯源技术的日益普及。

依包装类型划分

注射剂领域将在2026年占据最大的市场占有率，达到43.25%，同时也将以9.6%的年复合成长率成为成长最快的领域。生物药品和疫苗研发管线的扩张推动对先进系统的需求成长，这些系统需要严格的容器密封完整性测试（CCIT）和颗粒检测。

依剂型划分

口服药物领域在2024年创造了3.969亿美元的市场规模，主要得益于片剂和胶囊的高消费量。然而，随着无菌注射剂产量的不断成长，预计到2026年，注射剂市场将占据主导地位，市场占有率达到41.52%。生物药品和疫苗预计将以10.6%的年复合成长率（CAGR）成长，直至2034年。

依类型

全自动系统在2024年创造6.649亿美元的销售额，并将继续占据主导地位，这得益于其高效性和减少人为错误。在机器人技术和人工智慧工作流程整合的推动下，该细分市场正以9.2%的年复合成长率（CAGR）快速成长。

依最终使用者

药品公司将在2024年以5.29亿美元的销售额引领市场，这主要得益于现有生产线的现代化改造。生技公司预计将以10.0%的年复合成长率（CAGR）成长，这主要得益于其生物製品生产能力的扩张。

区域展望

亚太地区

亚太地区市场规模在2025年达到3.797亿美元，并在2026年达到4.166亿美元。预计到2034年，该地区将维持10.6%的最高年复合成长率。中国和印度是主要贡献者，预计到2026年，两国市场规模将分别达到2.045亿美元和6,190万美元。

北美

在强劲的研发投入和严格的监管合规的支撑下，北美地区在2025年和2026年分别纪录2.766亿美元和2.98亿美元的市场规模。光是美国预计在2026年就将达到2.569亿美元。

欧洲

在监管执法和检测技术创新的支持下，到2025年，欧洲创造2.25亿美元的收入。德国、英国和义大利仍将是主要贡献者。

南美洲及中东及非洲

到2025年，南美洲和中东及非洲地区的市场规模分别达到8,070万美元和6,010万美元。这主要归功于药品产量的增加和监管的改善。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 宏观与微观经济指标
  • 驱动因素、限制因素、机会与趋势

第4章 竞争格局

  • 主要公司采用的商业策略
  • 整合主要公司 SWOT 分析
  • 全球前3-5 大药品检测设备公司市场占有率/排名（2025年）

第5章 全球药品检测设备市场规模估算与预测：依细分市场划分（2021-2034年）

  • 主要发现
  • 依组件划分
    • 硬体
      • AVI 系统
      • X 射线侦测系统
      • 洩漏检测系统
      • 金属探测器
      • 检漏仪
      • 组合系统
      • 其他
    • 软体
  • 依包装类型划分
    • 注射剂
    • 瓶装
    • 泡罩包装
    • 其他
  • 依剂型
    • 口服
    • 注射剂
    • 生物製品/疫苗
    • 其他
  • 依类型
    • 全自动
    • 半自动
    • 手动
  • 依最终用户
    • 药品公司
    • 生技公司
    • 委託生产组织（CMO）与委託开发暨製造组织（CDMO）
    • 其他
  • 依地区
    • 北美
    • 南美
    • 欧洲
    • 亚太地区
    • 中东和非洲

第6章 北美药品检测设备市场规模估算与预测：依细分市场划分（2021-2034）

  • 依国家/地区
    • 美国
    • 加拿大
    • 墨西哥

第7章 南美洲药品检测设备市场规模估算与预测：依细分市场划分（2021-2034年）

  • 依国家划分
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 欧洲药品检测设备市场规模估算与预测：依细分市场划分（2021-2034年）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 其他欧洲国家

第9章 药品检测设备市场估算与预测亚太地区市场规模：依细分市场划分（2021-2034年）

  • 依国家划分
    • 中国
    • 日本
    • 韩国
    • 印度
    • 其他亚太地区

第10章 中东与非洲药品检测设备市场规模估计与预测：依细分市场划分（2021-2034年）

  • 依国家划分
    • GCC
    • 南非
    • 其他中东和非洲地区

第11章 前十大公司简介

  • ACG Group
  • Antares Vision Group
  • Cognex Corporation
  • Keyence Corporation
  • Mettler-Toledo
  • Minebea Intec
  • OPTEL Group
  • Stevanato Group
  • Syntegon Technology
  • Uhlmann Pac-Systeme

第12章 要点

Product Code: FBI114077

Growth Factors of pharmaceutical inspection machines Market

The global pharmaceutical inspection machines market size was valued at USD 1,022.10 million in 2025 and is projected to grow from USD 1,103.20 million in 2026 to USD 2,263.50 million by 2034, exhibiting a CAGR of 9.40% during the forecast period. Asia Pacific dominated the global market with a 37.20% share in 2025, reflecting strong pharmaceutical manufacturing expansion across emerging economies.

Pharmaceutical inspection machines are automated and semi-automated systems used in drug manufacturing to ensure product quality, packaging integrity, and regulatory compliance. These systems detect visual, dimensional, and packaging defects, verify labels and codes, and identify non-visible faults. Their adoption enhances throughput, reduces recall risks, ensures patient safety, and supports serialization and anti-counterfeit measures.

Market Dynamics

Market Drivers

Rising regulatory and quality compliance requirements are major drivers of market growth. Regulatory authorities such as the FDA and adherence to Good Manufacturing Practices (GMP) require strict validation processes for sterile manufacturing, serialization, and traceability. Advanced inspection technologies have significantly reduced drug recalls due to quality issues. Increasing pharmaceutical outsourcing in emerging regions has further strengthened the demand for standardized inspection systems across manufacturing sites.

Growing emphasis on patient safety and high-quality pharmaceutical products is compelling manufacturers to upgrade legacy inspection systems with automated and AI-enabled solutions.

Market Challenges

Despite strong growth potential, high capital expenditure (CAPEX) requirements pose a key challenge. Procurement involves lengthy Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) validation cycles, along with regulatory approvals. These extended validation timelines delay purchasing decisions and slow equipment refresh cycles, particularly for small and mid-sized manufacturers.

Market Opportunities

The adoption of AI-driven inspection systems and Software-as-a-Service (SaaS) platforms presents significant growth opportunities. AI-based deep-learning models reduce false rejects, improve detection accuracy, and enable predictive analytics. Subscription-based monitoring and model updates create recurring revenue streams for vendors.

In February 2021, Syntegon Technology installed one of the first fully validated AI-driven visual inspection systems, marking a milestone in smart manufacturing. Furthermore, Industry 4.0 integration, including sensor-enabled machines and connected production lines, is accelerating digital transformation in pharmaceutical facilities.

Market Trends

Integration of sensor fusion and combination inspection systems is a prominent trend. Manufacturers are deploying unified platforms combining vision systems, X-ray inspection, metal detection, checkweighing, and leak detection to reduce production line footprints and enhance defect detection accuracy.

Additionally, the rise of personalized medicine and biopharmaceutical production is encouraging the development of specialized inspection tools tailored for sterile injectables and biologics.

Segmentation Analysis

By Component

The hardware segment dominated with an 82.19% market share in 2026, generating USD 784.1 million in revenue. Strong demand for automated visual inspection (AVI), X-ray systems, leak detection systems, and combination machines drives hardware growth.

The software segment is projected to grow at the highest CAGR of 9.6%, supported by increasing adoption of AI-based analytics, serialization systems, and track-and-trace technologies.

By Packaging Type

The injectables segment held the largest share of 43.25% in 2026 and is also the fastest-growing segment with a CAGR of 9.6%. Growing biologics and vaccine pipelines require stringent container closure integrity testing (CCIT) and particle inspection, boosting demand for advanced systems.

By Formulation

The oral segment generated USD 396.9 million in 2024, driven by high consumption of tablets and capsules. However, the parenteral segment is projected to dominate with a 41.52% share in 2026 due to rising sterile injectable production. Biologics and vaccines are expected to grow at the highest CAGR of 10.6% through 2034.

By Type

Fully automated systems generated USD 664.9 million in 2024 and remain dominant due to efficiency and reduced manual errors. This segment is also the fastest-growing, with a CAGR of 9.2%, supported by robotics integration and AI-enabled workflows.

By End User

Pharmaceutical companies led the market with USD 529.0 million in 2024, driven by modernization of legacy production lines. Biotechnology companies are expected to grow at the highest CAGR of 10.0%, fueled by expanding biologics manufacturing capacity.

Regional Outlook

Asia Pacific

Asia Pacific generated USD 379.7 million in 2025 and is projected to reach USD 416.6 million in 2026, maintaining the highest CAGR of 10.6% through 2034. China and India are key contributors, expected to generate USD 204.5 million and USD 61.9 million respectively in 2026.

North America

North America recorded USD 276.6 million in 2025 and USD 298.0 million in 2026, driven by strong R&D investments and strict regulatory compliance. The U.S. alone accounted for USD 256.9 million in 2026.

Europe

Europe generated USD 225.0 million in 2025, supported by regulatory enforcement and innovation in inspection technologies. Germany, the U.K., and Italy remain key contributors.

South America and Middle East & Africa

South America and the Middle East & Africa reached USD 80.7 million and USD 60.1 million respectively in 2025, driven by pharmaceutical production expansion and regulatory improvements.

Competitive Landscape

The market is highly fragmented, with key players including ACG Group, Antares Vision Group, Cognex Corporation, Stevanato Group, Syntegon Technology, Uhlmann Pac-Systeme, Loma Systems, Mettler-Toledo, Minebea Intec, and OPTEL Group. Strategic partnerships, AI innovation, mergers, and product launches strengthen competitive positioning.

Conclusion

The pharmaceutical inspection machines market is set for strong growth, expanding from USD 1,022.10 million in 2025 to USD 2,263.50 million by 2034, at a CAGR of 9.40%. Rising regulatory compliance requirements, growth in biologics and injectables, and increasing adoption of AI-driven inspection systems are driving market expansion. Although high capital costs and lengthy validation cycles remain challenges, digital transformation and smart manufacturing initiatives are expected to sustain long-term market growth globally.

Segmentation By Component

  • Hardware
    • AVI Systems
    • X-Ray Inspection Systems
    • Leak Detection Systems
    • Metal Detectors
    • Checkweighers
    • Combination Systems
    • Others
  • Software

By Packaging Type

  • Injectables
  • Bottles
  • Blisters
  • Others

By Formulation

  • Oral
  • Parenteral
  • Biologics/Vaccines
  • Others

By Type

  • Fully Automated
  • Semi Automated
  • Manual

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • CMOs & CDMOs
  • Others

By Region

  • North America (By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • U.S. (By Type)
    • Canada (By Type)
    • Mexico (By Type)
  • Europe ( Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • U.K. (By Type)
    • Germany (By Type )
    • France (By Type )
    • Italy (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • China (By Type)
    • Japan (By Type)
    • India (By Type)
    • Rest of Asia Pacific (By Type)
  • South America (By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • Argentina (By Type)
    • Brazil (By Type)
    • Rest of South America (By Type)
  • Middle East & Africa (By Component, Packaging Type, Formulation, Type, End User, and Country/Sub-region)
    • GCC (By Type )
    • South Africa (By Type )
  • Rest of the Middle East & Africa (By Type )

Table of Content

1. Introduction

  • 1.1. Definition, By Segment
  • 1.2. Research Methodology/Approach
  • 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

  • 3.1. Macro and Micro Economic Indicators
  • 3.2. Drivers, Restraints, Opportunities and Trends

4. Competition Landscape

  • 4.1. Business Strategies Adopted by Key Players
  • 4.2. Consolidated SWOT Analysis of Key Players
  • 4.3. Global Pharmaceutical Inspection Machines Key Players (Top 3 - 5) Market Share/Ranking, 2025

5. Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 5.1. Key Findings
  • 5.2. By Component (USD)
    • 5.2.1. Hardware
      • 5.2.1.1. AVI Systems
      • 5.2.1.2. X-Ray Inspection Systems
      • 5.2.1.3. Leak Detection Systems
      • 5.2.1.4. Metal Detectors
      • 5.2.1.5. Checkweighers
      • 5.2.1.6. Combination Systems
      • 5.2.1.7. Others
    • 5.2.2. Software
  • 5.3. By Packaging Type (USD)
    • 5.3.1. Injectables
    • 5.3.2. Bottles
    • 5.3.3. Blisters
    • 5.3.4. Others
  • 5.4. By Formulation (USD)
    • 5.4.1. Oral
    • 5.4.2. Parenteral
    • 5.4.3. Biologics/Vaccines
    • 5.4.4. Others
  • 5.5. By Type (USD)
    • 5.5.1. Fully Automated
    • 5.5.2. Semi Automated
    • 5.5.3. Manual
  • 5.6. By End User (USD)
    • 5.6.1. Pharmaceutical Companies
    • 5.6.2. Biotechnology Companies
    • 5.6.3. CMOs & CDMOs
    • 5.6.4. Others
  • 5.7. By Region (USD)
    • 5.7.1. North America
    • 5.7.2. South America
    • 5.7.3. Europe
    • 5.7.4. Asia Pacific
    • 5.7.5. Middle East & Africa

6. North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 6.1. Key Findings
  • 6.2. By Component (USD)
    • 6.2.1. Hardware
      • 6.2.1.1. AVI Systems
      • 6.2.1.2. X-Ray Inspection Systems
      • 6.2.1.3. Leak Detection Systems
      • 6.2.1.4. Metal Detectors
      • 6.2.1.5. Checkweighers
      • 6.2.1.6. Combination Systems
      • 6.2.1.7. Others
    • 6.2.2. Software
  • 6.3. By Packaging Type (USD)
    • 6.3.1. Injectables
    • 6.3.2. Bottles
    • 6.3.3. Blisters
    • 6.3.4. Others
  • 6.4. By Formulation (USD)
    • 6.4.1. Oral
    • 6.4.2. Parenteral
    • 6.4.3. Biologics/Vaccines
    • 6.4.4. Others
  • 6.5. By Type (USD)
    • 6.5.1. Fully Automated
    • 6.5.2. Semi Automated
    • 6.5.3. Manual
  • 6.6. By End User (USD)
    • 6.6.1. Pharmaceutical Companies
    • 6.6.2. Biotechnology Companies
    • 6.6.3. CMOs & CDMOs
    • 6.6.4. Others
  • 6.7. By Country (USD)
    • 6.7.1. U.S.
      • 6.7.1.1. By Type (USD)
    • 6.7.2. Canada
      • 6.7.2.1. By Type (USD)
    • 6.7.3. Mexico
      • 6.7.3.1. By Type (USD)

7. South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 7.1. Key Findings
  • 7.2. By Component (USD)
    • 7.2.1. Hardware
      • 7.2.1.1. AVI Systems
      • 7.2.1.2. X-Ray Inspection Systems
      • 7.2.1.3. Leak Detection Systems
      • 7.2.1.4. Metal Detectors
      • 7.2.1.5. Checkweighers
      • 7.2.1.6. Combination Systems
      • 7.2.1.7. Others
    • 7.2.2. Software
  • 7.3. By Packaging Type (USD)
    • 7.3.1. Injectables
    • 7.3.2. Bottles
    • 7.3.3. Blisters
    • 7.3.4. Others
  • 7.4. By Formulation (USD)
    • 7.4.1. Oral
    • 7.4.2. Parenteral
    • 7.4.3. Biologics/Vaccines
    • 7.4.4. Others
  • 7.5. By Type (USD)
    • 7.5.1. Fully Automated
    • 7.5.2. Semi Automated
    • 7.5.3. Manual
  • 7.6. By End User (USD)
    • 7.6.1. Pharmaceutical Companies
    • 7.6.2. Biotechnology Companies
    • 7.6.3. CMOs & CDMOs
    • 7.6.4. Others
  • 7.7. By Country (USD)
    • 7.7.1. Brazil
      • 7.7.1.1. By Type (USD)
    • 7.7.2. Argentina
      • 7.7.2.1. By Type (USD)
    • 7.7.3. Rest of South America

8. Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 8.1. Key Findings
  • 8.2. By Component (USD)
    • 8.2.1. Hardware
      • 8.2.1.1. AVI Systems
      • 8.2.1.2. X-Ray Inspection Systems
      • 8.2.1.3. Leak Detection Systems
      • 8.2.1.4. Metal Detectors
      • 8.2.1.5. Checkweighers
      • 8.2.1.6. Combination Systems
      • 8.2.1.7. Others
    • 8.2.2. Software
  • 8.3. By Packaging Type (USD)
    • 8.3.1. Injectables
    • 8.3.2. Bottles
    • 8.3.3. Blisters
    • 8.3.4. Others
  • 8.4. By Formulation (USD)
    • 8.4.1. Oral
    • 8.4.2. Parenteral
    • 8.4.3. Biologics/Vaccines
    • 8.4.4. Others
  • 8.5. By Type (USD)
    • 8.5.1. Fully Automated
    • 8.5.2. Semi Automated
    • 8.5.3. Manual
  • 8.6. By End User (USD)
    • 8.6.1. Pharmaceutical Companies
    • 8.6.2. Biotechnology Companies
    • 8.6.3. CMOs & CDMOs
    • 8.6.4. Others
  • 8.7. By Country (USD)
    • 8.7.1. Germany
      • 8.7.1.1. By Type (USD)
    • 8.7.2. U.K.
      • 8.7.2.1. By Type (USD)
    • 8.7.3. France
      • 8.7.3.1. By Type (USD)
    • 8.7.4. Italy
      • 8.7.4.1. By Type (USD)
    • 8.7.5. Rest of Europe

9. Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 9.1. Key Findings
  • 9.2. By Component (USD)
    • 9.2.1. Hardware
      • 9.2.1.1. AVI Systems
      • 9.2.1.2. X-Ray Inspection Systems
      • 9.2.1.3. Leak Detection Systems
      • 9.2.1.4. Metal Detectors
      • 9.2.1.5. Checkweighers
      • 9.2.1.6. Combination Systems
      • 9.2.1.7. Others
    • 9.2.2. Software
  • 9.3. By Packaging Type (USD)
    • 9.3.1. Injectables
    • 9.3.2. Bottles
    • 9.3.3. Blisters
    • 9.3.4. Others
  • 9.4. By Formulation (USD)
    • 9.4.1. Oral
    • 9.4.2. Parenteral
    • 9.4.3. Biologics/Vaccines
    • 9.4.4. Others
  • 9.5. By Type (USD)
    • 9.5.1. Fully Automated
    • 9.5.2. Semi Automated
    • 9.5.3. Manual
  • 9.6. By End User (USD)
    • 9.6.1. Pharmaceutical Companies
    • 9.6.2. Biotechnology Companies
    • 9.6.3. CMOs & CDMOs
    • 9.6.4. Others
  • 9.7. By Country (USD)
    • 9.7.1. China
      • 9.7.1.1. By Type (USD)
    • 9.7.2. Japan
      • 9.7.2.1. By Type (USD)
    • 9.7.3. South Korea
      • 9.7.3.1. By Type (USD)
    • 9.7.4. India
      • 9.7.4.1. By Type (USD)
    • 9.7.5. Rest of Asia Pacific

10. Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Segments, 2021-2034

  • 10.1. Key Findings
  • 10.2. By Component (USD)
    • 10.2.1. Hardware
      • 10.2.1.1. AVI Systems
      • 10.2.1.2. X-Ray Inspection Systems
      • 10.2.1.3. Leak Detection Systems
      • 10.2.1.4. Metal Detectors
      • 10.2.1.5. Checkweighers
      • 10.2.1.6. Combination Systems
      • 10.2.1.7. Others
    • 10.2.2. Software
  • 10.3. By Packaging Type (USD)
    • 10.3.1. Injectables
    • 10.3.2. Bottles
    • 10.3.3. Blisters
    • 10.3.4. Others
  • 10.4. By Formulation (USD)
    • 10.4.1. Oral
    • 10.4.2. Parenteral
    • 10.4.3. Biologics/Vaccines
    • 10.4.4. Others
  • 10.5. By Type (USD)
    • 10.5.1. Fully Automated
    • 10.5.2. Semi Automated
    • 10.5.3. Manual
  • 10.6. By End User (USD)
    • 10.6.1. Pharmaceutical Companies
    • 10.6.2. Biotechnology Companies
    • 10.6.3. CMOs & CDMOs
    • 10.6.4. Others
  • 10.7. By Country (USD)
    • 10.7.1. GCC
      • 10.7.1.1. By Type (USD)
    • 10.7.2. South Africa
      • 10.7.2.1. By Type (USD)
    • 10.7.3. Rest of MEA

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

  • 11.1. ACG Group
    • 11.1.1. Overview
      • 11.1.1.1. Key Management
      • 11.1.1.2. Headquarters
      • 11.1.1.3. Offerings/Business Segments
    • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.1.2.1. Employee Size
      • 11.1.2.2. Past and Current Revenue
      • 11.1.2.3. Geographical Share
      • 11.1.2.4. Business Segment Share
      • 11.1.2.5. Recent Developments
  • 11.2. Antares Vision Group
    • 11.2.1. Overview
      • 11.2.1.1. Key Management
      • 11.2.1.2. Headquarters
      • 11.2.1.3. Offerings/Business Segments
    • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.2.2.1. Employee Size
      • 11.2.2.2. Past and Current Revenue
      • 11.2.2.3. Geographical Share
      • 11.2.2.4. Business Segment Share
      • 11.2.2.5. Recent Developments
  • 11.3. Cognex Corporation
    • 11.3.1. Overview
      • 11.3.1.1. Key Management
      • 11.3.1.2. Headquarters
      • 11.3.1.3. Offerings/Business Segments
    • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.3.2.1. Employee Size
      • 11.3.2.2. Past and Current Revenue
      • 11.3.2.3. Geographical Share
      • 11.3.2.4. Business Segment Share
      • 11.3.2.5. Recent Developments
  • 11.4. Keyence Corporation
    • 11.4.1. Overview
      • 11.4.1.1. Key Management
      • 11.4.1.2. Headquarters
      • 11.4.1.3. Offerings/Business Segments
    • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.4.2.1. Employee Size
      • 11.4.2.2. Past and Current Revenue
      • 11.4.2.3. Geographical Share
      • 11.4.2.4. Business Segment Share
      • 11.4.2.5. Recent Developments
  • 11.5. Mettler-Toledo
    • 11.5.1. Overview
      • 11.5.1.1. Key Management
      • 11.5.1.2. Headquarters
      • 11.5.1.3. Offerings/Business Segments
    • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.5.2.1. Employee Size
      • 11.5.2.2. Past and Current Revenue
      • 11.5.2.3. Geographical Share
      • 11.5.2.4. Business Segment Share
      • 11.5.2.5. Recent Developments
  • 11.6. Minebea Intec
    • 11.6.1. Overview
      • 11.6.1.1. Key Management
      • 11.6.1.2. Headquarters
      • 11.6.1.3. Offerings/Business Segments
    • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.6.2.1. Employee Size
      • 11.6.2.2. Past and Current Revenue
      • 11.6.2.3. Geographical Share
      • 11.6.2.4. Business Segment Share
      • 11.6.2.5. Recent Developments
  • 11.7. OPTEL Group
    • 11.7.1. Overview
      • 11.7.1.1. Key Management
      • 11.7.1.2. Headquarters
      • 11.7.1.3. Offerings/Business Segments
    • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.7.2.1. Employee Size
      • 11.7.2.2. Past and Current Revenue
      • 11.7.2.3. Geographical Share
      • 11.7.2.4. Business Segment Share
      • 11.7.2.5. Recent Developments
  • 11.8. Stevanato Group
    • 11.8.1. Overview
      • 11.8.1.1. Key Management
      • 11.8.1.2. Headquarters
      • 11.8.1.3. Offerings/Business Segments
    • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.8.2.1. Employee Size
      • 11.8.2.2. Past and Current Revenue
      • 11.8.2.3. Geographical Share
      • 11.8.2.4. Business Segment Share
      • 11.8.2.5. Recent Developments
  • 11.9. Syntegon Technology
    • 11.9.1. Overview
      • 11.9.1.1. Key Management
      • 11.9.1.2. Headquarters
      • 11.9.1.3. Offerings/Business Segments
    • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.9.2.1. Employee Size
      • 11.9.2.2. Past and Current Revenue
      • 11.9.2.3. Geographical Share
      • 11.9.2.4. Business Segment Share
      • 11.9.2.5. Recent Developments
  • 11.10. Uhlmann Pac-Systeme
    • 11.10.1. Overview
      • 11.10.1.1. Key Management
      • 11.10.1.2. Headquarters
      • 11.10.1.3. Offerings/Business Segments
    • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
      • 11.10.2.1. Employee Size
      • 11.10.2.2. Past and Current Revenue
      • 11.10.2.3. Geographical Share
      • 11.10.2.4. Business Segment Share
      • 11.10.2.5. Recent Developments

12. Key Takeaways

List of Tables

  • Table 1: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 2: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 3: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 4: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 5: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 6: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 7: Global Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Region, 2021 - 2034
  • Table 8: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 9: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 10: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 11: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 12: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 13: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 14: North America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 15: U.S. Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 16: Canada Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 17: Mexico Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 18: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 19: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 20: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 21: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 22: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 23: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 24: Europe Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 25: Germany Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 26: France Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 27: Italy Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 28: United Kingdom Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 29: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 30: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 31: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 32: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 33: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 34: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 35: Asia Pacific Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 36: China Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 37: Japan Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 38: India Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 39: South Korea Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 40: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 41: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 42: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 43: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 44: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 45: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 46: Middle East & Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 47: GCC Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 48: South Africa Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 49: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, 2021 - 2034
  • Table 50: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Component, 2021 - 2034
  • Table 51: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Packaging Type, 2021 - 2034
  • Table 52: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Formulation, 2021 - 2034
  • Table 53: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 54: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By End User, 2021 - 2034
  • Table 55: South America Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Country, 2021 - 2034
  • Table 56: Brazil Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034
  • Table 57: Argentina Pharmaceutical Inspection Machines Market Size Estimates and Forecasts, By Type, 2021 - 2034

List of Figures

  • Figure 1: Global Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 2: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 3: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 4: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 5: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 6: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 7: Global Pharmaceutical Inspection Machines Market Revenue Share (%), By Region, 2025 and 2034
  • Figure 8: North America Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 9: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 10: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 11: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 12: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 13: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 14: North America Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 15: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 16: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 17: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 18: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 19: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 20: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 21: Europe Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 22: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 23: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 24: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 25: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 26: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 27: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 28: Asia Pacific Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 29: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 30: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 31: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 32: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 33: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 34: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 35: Middle East & Africa Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 36: South America Pharmaceutical Inspection Machines Market Revenue Share (%), 2025 and 2034
  • Figure 37: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Component, 2025 and 2034
  • Figure 38: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Packaging Type, 2025 and 2034
  • Figure 39: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Formulation, 2025 and 2034
  • Figure 40: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Type, 2025 and 2034
  • Figure 41: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By End User, 2025 and 2034
  • Figure 42: South America Pharmaceutical Inspection Machines Market Revenue Share (%), By Country, 2025 and 2034
  • Figure 43: Global Pharmaceutical Inspection Machines Key Players' Market Share/Ranking (%), 2025